v3.26.1
Statement of Operations
 1 Months Ended 12 Months Ended
Jul. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Jul. 31, 2025
USD ($)
$ / shares
shares
Jul. 31, 2025
MYR (RM)
shares
Dec. 31, 2024
USD ($)
Jul. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Operating expenses:              
General and administrative expenses $ (3,947)   $ (163,173)        
Total operating expenses (3,947)   (163,173)        
Other income (expense):              
Net income $ (3,947)   $ (163,173)        
Earnings per share              
Basic | $ / shares $ (3,947)   $ (163,173)        
Diluted | $ / shares $ (3,947)   $ (163,173)        
Weighted average number of ordinary shares              
Basic | shares 1   1 1      
Diluted | shares 1   1 1      
Titan Pharmaceuticals Inc [Member]              
Operating expenses:              
General and administrative expenses   $ 2,415,000     $ 4,557,000    
Total operating expenses   2,415,000     4,557,000    
Income from operations   (2,415,000)     (4,557,000)    
Other income (expense):              
Interest expense       1,000    
Other income/(expense)   (70,000)     (150,000)    
Total other income/(expenses), net   (70,000)     (149,000)    
Income tax expense       1,000    
Net income   $ (2,485,000)     $ (4,706,000)    
Earnings per share              
Basic | $ / shares   $ (2,937)         $ (7,319)
Diluted | $ / shares   $ (2,937)         $ (7,319)
Weighted average number of ordinary shares              
Basic | shares   846         643
Diluted | shares   846         643
TALENTEC SDN. BHD. [Member]              
Revenues     $ 2,683,126     $ 2,124,496  
Cost of revenues     1,798,198     1,437,661  
Gross profit     884,928 RM 50,000,000   686,835  
Operating expenses:              
Selling and marketing expenses     24,773     16,822  
General and administrative expenses     634,105     551,353  
Total operating expenses     658,878     568,175  
Income from operations     226,050     118,660  
Other income (expense):              
Interest expense     (13,905)     (48,329)  
Other income/(expense)     (2,234)     82,896  
Total other income/(expenses), net     (16,139)     34,567  
Income before income taxes     209,911     153,227  
Income tax expense          
Net income     209,911     153,227  
Other comprehensive income:              
Foreign currency translation adjustment, net of tax     64,567     (30,932)  
Comprehensive income     $ 274,478     $ 122,295  
Earnings per share              
Basic | $ / shares     $ 0.36     $ 0.31  
Diluted | $ / shares     $ 0.36     $ 0.31  
Weighted average number of ordinary shares              
Basic | shares     580,000 580,000   501,312  
Diluted | shares     580,000 580,000   501,312